Loading data
HCMNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 548.51 m USD | 630.2 m USD | 838 m USD | 426.41 m USD | 356.13 m USD |
| Cost of revenue | 336.35 m USD | 348.88 m USD | 384.45 m USD | 311.1 m USD | — |
| Research and development expense | 148.3 m USD | 212.11 m USD | 302 m USD | 386.89 m USD | 299.09 m USD |
| Operating profit | -39.16 m USD | -43.71 m USD | 18.38 m USD | -407.69 m USD | -328.32 m USD |
| Interest expense | — | — | 759 k USD | 652 k USD | 592 k USD |
| Income tax expense | 63.61 m USD | 7.19 m USD | 4.51 m USD | -283 k USD | 11.92 m USD |
| Net income (reported basis) | 456.91 m USD | 37.73 m USD | 100.78 m USD | -360.84 m USD | -194.65 m USD |
| Basic earnings per share | 0.53 USD/share | 0.04 USD/share | 0.12 USD/share | -0.43 USD/share | -0.25 USD/share |
| Diluted earnings per share | 0.52 USD/share | 0.04 USD/share | 0.12 USD/share | -0.43 USD/share | -0.25 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.